These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 12090760

  • 1. Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells.
    DiFalco MR, Congote LF.
    Cytokine; 2002 Apr 07; 18(1):51-60. PubMed ID: 12090760
    [Abstract] [Full Text] [Related]

  • 2. Thrombospondin 1, produced by endothelial cells under the action of erythropoietin, stimulates thymidine incorporation into erythroid cells and counteracts the inhibitory action of insulin-like growth factor binding protein 3.
    Congote LF, DiFalco MR, Gibbs BF.
    Cytokine; 2005 Jun 07; 30(5):248-53. PubMed ID: 15927849
    [Abstract] [Full Text] [Related]

  • 3. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
    Harrison J, Kappas A, Levere RD, Lutton JD, Chertkov JL, Jiang S, Abraham NG.
    Blood; 1993 Dec 15; 82(12):3574-9. PubMed ID: 8260696
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of zidovudine in erythroid progenitor cells. Reversal with a combination of erythropoietin and interleukin-3.
    Gogu SR, Beckman BS, Wilson RB, Agrawal KC.
    Biochem Pharmacol; 1995 Jul 31; 50(3):413-9. PubMed ID: 7646543
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells.
    Weich NS, Tullai J, Guido E, McMahon M, Jolliffe LK, Lopez AF, Vadas MA, Lowry PA, Quesenberry PJ, Rosen J.
    Exp Hematol; 1993 May 31; 21(5):647-55. PubMed ID: 8513865
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L, Xiao M, Li ZH, Jolliffe LK, Jones S, Broxmeyer HE, Weich N.
    Exp Hematol; 1995 Sep 31; 23(10):1130-4. PubMed ID: 7656932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 31; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 10. In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine.
    Gallicchio VS, Hughes NK, Tse KF.
    Cytokine; 1993 Jan 31; 5(1):62-71. PubMed ID: 8485306
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin-dependent endothelial proteins: potential use against erythropoietin resistance.
    Congote LF, Sadvakassova G, Dobocan MC, Difalco MR, Li Q.
    Cytokine; 2010 Aug 31; 51(2):113-8. PubMed ID: 20399679
    [Abstract] [Full Text] [Related]

  • 12. Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse.
    Brox AG, Zhang F, Guyda H, Gagnon RF.
    Kidney Int; 1996 Sep 31; 50(3):937-43. PubMed ID: 8872969
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice.
    Difalco MR, Dufresne L, Congote LF.
    J Pharmacol Exp Ther; 1998 Feb 31; 284(2):449-54. PubMed ID: 9454783
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS, Hughes NK, Hulette BC, Noblitt L.
    J Leukoc Biol; 1991 Dec 31; 50(6):580-6. PubMed ID: 1940611
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.
    Corre-Buscail I, Pineau D, Boissinot M, Hermouet S.
    Exp Hematol; 2005 Nov 31; 33(11):1299-308. PubMed ID: 16263414
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-4 suppresses the interleukin-3 dependent erythroid colony formation from normal human bone marrow cells.
    de Wolf JT, Beentjes JA, Esselink MT, Smit JW, Halie MR, Vellenga E.
    Br J Haematol; 1990 Mar 31; 74(3):246-50. PubMed ID: 2334633
    [Abstract] [Full Text] [Related]

  • 18. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS, Hughes NK, Tse KF, Ling J, Gaines H, Bowen TE, Uluitu M.
    Int J Immunopharmacol; 1995 Nov 31; 17(11):865-78. PubMed ID: 8788116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors.
    Miyagawa S, Kobayashi M, Konishi N, Sato T, Ueda K.
    Br J Haematol; 2000 Jun 31; 109(3):555-62. PubMed ID: 10886204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.